Search

Michelle M. Iacoletti

Examiner (ID: 9693, Phone: (571)270-5789 , Office: P/2882 )

Most Active Art Unit
2882
Art Unit(s)
2882, 4185, 4100, 2877
Total Applications
628
Issued Applications
540
Pending Applications
11
Abandoned Applications
82

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13328467 [patent_doc_number] => 20180215771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => TUNABLE RARE-EARTH FCU-METAL-ORGANIC FRAMEWORKS [patent_app_type] => utility [patent_app_number] => 15/926511 [patent_app_country] => US [patent_app_date] => 2018-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11174 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15926511 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/926511
Tunable rare-earth fcu-metal-organic frameworks Mar 19, 2018 Issued
Array ( [id] => 16946651 [patent_doc_number] => 20210205342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => NICOTINAMIDE RIBOSIDE FOR USE IN TREATING OR PREVENTING LIVER DAMAGE [patent_app_type] => utility [patent_app_number] => 16/494581 [patent_app_country] => US [patent_app_date] => 2018-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494581 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/494581
Nicotinamide riboside for use in treating or preventing liver damage Mar 15, 2018 Issued
Array ( [id] => 13300857 [patent_doc_number] => 20180201965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => METHOD FOR PRODUCING GALACTOOLIGOSACCHARIDES FROM LACTOSE [patent_app_type] => utility [patent_app_number] => 15/923957 [patent_app_country] => US [patent_app_date] => 2018-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11838 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923957 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/923957
Method for producing galactooligosaccharides from lactose Mar 15, 2018 Issued
Array ( [id] => 15618807 [patent_doc_number] => 20200079808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-12 [patent_title] => GLYCOPOLYMERS SEQUESTERING CARBOHYDRATE-BINDING PROTEINS [patent_app_type] => utility [patent_app_number] => 16/493959 [patent_app_country] => US [patent_app_date] => 2018-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31969 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493959 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/493959
GLYCOPOLYMERS SEQUESTERING CARBOHYDRATE-BINDING PROTEINS Mar 14, 2018 Abandoned
Array ( [id] => 12908770 [patent_doc_number] => 20180194765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-12 [patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING BETA-LACTAMASE [patent_app_type] => utility [patent_app_number] => 15/917059 [patent_app_country] => US [patent_app_date] => 2018-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15917059 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/917059
Compositions and methods for inhibiting b-lactamase Mar 8, 2018 Issued
Array ( [id] => 13957813 [patent_doc_number] => 20190055250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS [patent_app_type] => utility [patent_app_number] => 15/914047 [patent_app_country] => US [patent_app_date] => 2018-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29281 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -56 [patent_words_short_claim] => 2124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15914047 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/914047
Heterocyclic compounds as LSD1 inhibitors Mar 6, 2018 Issued
Array ( [id] => 19134528 [patent_doc_number] => 11969437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Alginate liquid preparation [patent_app_type] => utility [patent_app_number] => 16/491709 [patent_app_country] => US [patent_app_date] => 2018-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 9275 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491709 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/491709
Alginate liquid preparation Mar 5, 2018 Issued
Array ( [id] => 16673061 [patent_doc_number] => 20210061824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => SILANOL COMPOUND AND METHOD FOR PRODUCING SILANOL COMPOUND [patent_app_type] => utility [patent_app_number] => 16/606487 [patent_app_country] => US [patent_app_date] => 2018-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11078 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606487 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/606487
SILANOL COMPOUND AND METHOD FOR PRODUCING SILANOL COMPOUND Mar 4, 2018 Abandoned
Array ( [id] => 12880573 [patent_doc_number] => 20180185366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => Inhibitors of Multidrug Resistance Transporter P-Glycoprotein [patent_app_type] => utility [patent_app_number] => 15/911441 [patent_app_country] => US [patent_app_date] => 2018-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13737 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15911441 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/911441
Inhibitors of multidrug resistance transporter P-glycoprotein Mar 4, 2018 Issued
Array ( [id] => 17586530 [patent_doc_number] => 11324772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-10 [patent_title] => Periodontal gel composition and method of use [patent_app_type] => utility [patent_app_number] => 16/487337 [patent_app_country] => US [patent_app_date] => 2018-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 8653 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487337 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/487337
Periodontal gel composition and method of use Feb 26, 2018 Issued
Array ( [id] => 16806044 [patent_doc_number] => 20210128597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => THE HSP90 ACTIVATOR AHA1 DRIVES PRODUCTION OF PATHOLOGICAL TAU AGGREGATES [patent_app_type] => utility [patent_app_number] => 16/486975 [patent_app_country] => US [patent_app_date] => 2018-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486975 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/486975
Hsp90 activator Aha1 drives production of pathological tau aggregates Feb 22, 2018 Issued
Array ( [id] => 15342555 [patent_doc_number] => 20200009169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => COMPOUNDS, COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF LIVER, LIPID, AND GLUCOSE-RELATED CONDITIONS [patent_app_type] => utility [patent_app_number] => 16/487829 [patent_app_country] => US [patent_app_date] => 2018-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7017 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487829 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/487829
COMPOUNDS, COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF LIVER, LIPID, AND GLUCOSE-RELATED CONDITIONS Feb 19, 2018 Abandoned
Array ( [id] => 12837277 [patent_doc_number] => 20180170932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => PURINE DIONES AS WNT PATHWAY MODULATORS [patent_app_type] => utility [patent_app_number] => 15/899675 [patent_app_country] => US [patent_app_date] => 2018-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15899675 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/899675
Purine diones as Wnt pathway modulators Feb 19, 2018 Issued
Array ( [id] => 18932371 [patent_doc_number] => 11884779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Ionically modified silicones, compositions, and medical devices formed therefrom [patent_app_type] => utility [patent_app_number] => 16/482739 [patent_app_country] => US [patent_app_date] => 2018-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11890 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 509 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16482739 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/482739
Ionically modified silicones, compositions, and medical devices formed therefrom Feb 15, 2018 Issued
Array ( [id] => 12837226 [patent_doc_number] => 20180170915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => 5-BROMO-INDIRUBINS [patent_app_type] => utility [patent_app_number] => 15/898151 [patent_app_country] => US [patent_app_date] => 2018-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22892 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 275 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15898151 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/898151
5-BROMO-INDIRUBINS Feb 14, 2018 Abandoned
Array ( [id] => 17741421 [patent_doc_number] => 11389466 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => Multivalent fucose derivatives for use as a drug [patent_app_type] => utility [patent_app_number] => 16/485899 [patent_app_country] => US [patent_app_date] => 2018-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 23689 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 282 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485899 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/485899
Multivalent fucose derivatives for use as a drug Feb 14, 2018 Issued
15/894118 COMPOUNDS AND METHODS FOR TREATING AUTOIMMUNITY Feb 11, 2018 Abandoned
Array ( [id] => 17814251 [patent_doc_number] => 11419838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome [patent_app_type] => utility [patent_app_number] => 15/892078 [patent_app_country] => US [patent_app_date] => 2018-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7337 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15892078 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/892078
Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome Feb 7, 2018 Issued
Array ( [id] => 15265389 [patent_doc_number] => 20190381428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => Selective Polysaccharide Flocculants for Bauxite Ore Beneficiation [patent_app_type] => utility [patent_app_number] => 16/480547 [patent_app_country] => US [patent_app_date] => 2018-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7498 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480547 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/480547
Selective Polysaccharide Flocculants for Bauxite Ore Beneficiation Feb 6, 2018 Abandoned
Array ( [id] => 17602865 [patent_doc_number] => 11331334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Intranasal composition of methylcobalamin [patent_app_type] => utility [patent_app_number] => 16/482491 [patent_app_country] => US [patent_app_date] => 2018-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4707 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16482491 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/482491
Intranasal composition of methylcobalamin Feb 4, 2018 Issued
Menu